Stereotactic radiotherapy for metastatic kidney cancer

A paper published in the European Journal of Cancer earlier this month reports on the experience of six French hospitals with stereotactic radiotherapy (SRT) for metastatic renal cell carcinoma (RCC) between 2008 and 2015 . This retrospective study showed a 12-month local control rate of metastases of 82.9%. Twenty-five percent of patients with oligometastatic disease […]

read more

Stereotactic radiotherapy for the treatment of metastatic renal cell carcinoma

Results from a recent retrospective study from France, published in the journal Oncology,┬áhave shown that stereotactic radiotherapy is safe and effective for metastatic renal cell carcinoma (RCC) patients with metastases in one or two other parts of the body (oligometastatic or oligoprogressive). Stereotactic radiotherapy may also delay the start or change of systemic (drug) therapy. […]

read more
Showing all 2 results
  TOP